Page last updated: 2024-08-26

4-hydroxyphenylglycine and ALS - Amyotrophic Lateral Sclerosis

4-hydroxyphenylglycine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cairns, NJ; Ferrario, M; Liberini, P; Moretto, G; Paterlini, M; Pizzi, M; Spano, P; Valerio, A1

Other Studies

1 other study(ies) available for 4-hydroxyphenylglycine and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 73, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Survival; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Ganglia, Spinal; Glycine; Humans; Immunohistochemistry; Kainic Acid; Motor Neurons; Nerve Degeneration; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Spinal Cord

2002